SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-330997
Filing Date
2017-11-02
Accepted
2017-11-02 16:12:56
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d423301d10q.htm 10-Q 694516
2 EX-31.1 d423301dex311.htm EX-31.1 9463
3 EX-31.2 d423301dex312.htm EX-31.2 9336
4 EX-32.1 d423301dex321.htm EX-32.1 5770
  Complete submission text file 0001193125-17-330997.txt   3271488

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gbt-20170930.xml EX-101.INS 551763
6 XBRL TAXONOMY EXTENSION SCHEMA gbt-20170930.xsd EX-101.SCH 36030
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20170930_cal.xml EX-101.CAL 52676
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20170930_def.xml EX-101.DEF 134371
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20170930_lab.xml EX-101.LAB 315045
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20170930_pre.xml EX-101.PRE 235571
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 171172477
SIC: 2834 Pharmaceutical Preparations